Effects of repeated phencyclidine treatment on serotonin transporter in rat brain

被引:9
作者
Hori, T [1 ]
Abe, S [1 ]
Baba, A [1 ]
Suzuki, T [1 ]
Shiraishi, H [1 ]
机构
[1] Univ Tsukuba, Inst Clin Med, Dept Psychiat, Tsukuba, Ibaraki 3058575, Japan
关键词
phencyclidine; stereotyped behavior; tolerance; serotonin transporter; paroxetine; rat brain;
D O I
10.1016/S0304-3940(99)00991-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Phencyclidine (PCP) is known to be an inhibitor of serotonin (5-MT) uptake and to increase serotonergic activity. The development of tolerance to serotonergic stereotyped behaviors induced by repeated PCP treatment and changes of 5-HT transporters were examined. Backpedalling was significantly reduced in frequency following 14 days PCP treatment (7.5 mg/kg per day). Furthermore, repeated PCP treatment decreased the equilibrium dissociation constant (Kd) Of [H-3]paroxetine binding to 5-HT transporters in whole brain excluding the cerebellum without any change of maximum number of binding sites (B-max). Single treatment with PCP failed to change binding parameters. These results indicate that repeated PCP treatment causes tolerance in serotonergic stereotyped behavior and increases affinity of 5-HT trans porters for [H-3]paroxetine binding. The increased affinity of 5-HT transporters could represent compensatory responses to chronic inhibition of 5-HT uptake by PCP, (C) 2000 Elsevier Science ireland Ltd. All rights reserved.
引用
收藏
页码:53 / 56
页数:4
相关论文
共 23 条
  • [1] BEHAVIORAL PHARMACOLOGY OF PHENCYCLIDINE
    BALSTER, RL
    CHAIT, LD
    [J]. CLINICAL TOXICOLOGY, 1976, 9 (04): : 513 - 528
  • [2] ACUTE AND CHRONIC PHENCYCLIDINE EFFECTS ON LOCOMOTOR-ACTIVITY, STEREOTYPY AND ATAXIA IN RATS
    CASTELLANI, S
    ADAMS, PM
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1981, 73 (2-3) : 143 - 154
  • [3] [H-3] PAROXETINE BINDING IN RAT FRONTAL-CORTEX STRONGLY CORRELATES WITH [H-3] 5-HT UPTAKE - EFFECT OF ADMINISTRATION OF VARIOUS ANTIDEPRESSANT TREATMENTS
    CHEETHAM, SC
    VIGGERS, JA
    SLATER, NA
    HEAL, DJ
    BUCKETT, WR
    [J]. NEUROPHARMACOLOGY, 1993, 32 (08) : 737 - 743
  • [4] RELATIONSHIP BETWEEN THE DEVELOPMENT OF BEHAVIORAL TOLERANCE AND THE BIODISPOSITION OF PHENCYCLIDINE IN MICE
    FREEMAN, AS
    MARTIN, BR
    BALSTER, RL
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1984, 20 (03) : 373 - 377
  • [5] Gorelick David A., 1995, P1767
  • [6] ACUTE AND CHRONIC BEHAVIORAL INTERACTIONS BETWEEN PHENCYCLIDINE (PCP) AND AMPHETAMINE - EVIDENCE FOR A DOPAMINERGIC ROLE IN SOME PCP-INDUCED BEHAVIORS
    GREENBERG, BD
    SEGAL, DS
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1985, 23 (01) : 99 - 105
  • [7] CHARACTERIZATION OF [H-3] PAROXETINE BINDING TO RAT CORTICAL MEMBRANES
    HABERT, E
    GRAHAM, D
    TAHRAOUI, L
    CLAUSTRE, Y
    LANGER, SZ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 118 (1-2) : 107 - 114
  • [8] Effects of phencyclidine metabolites on serotonin uptake in rat brain
    Hori, T
    Suzuki, T
    Baba, A
    Abe, S
    Yamamoto, T
    Moroji, T
    Shiraishi, H
    [J]. NEUROSCIENCE LETTERS, 1996, 209 (03) : 153 - 156
  • [9] JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301
  • [10] Altered frontal cortical dopaminergic transmission in monkeys after subchronic phencyclidine exposure: Involvement in frontostriatal cognitive deficits
    Jentsch, JD
    Taylor, JR
    Elsworth, JD
    Redmond, DE
    Roth, RH
    [J]. NEUROSCIENCE, 1999, 90 (03) : 823 - 832